Tanell Ogbeide, C.F.N.P

NPI: 1609108687
Total Payments
$1,125
2024 Payments
$110.40
Companies
9
Transactions
12
Medicare Patients
868
Medicare Billing
$56,517

Payment Breakdown by Category

Food & Beverage$1,125 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,125 12 100.0%

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim Pharmaceuticals, Inc. $241.00 2 $0 (2022)
Novo Nordisk Inc $212.02 3 $0 (2024)
Amgen Inc. $148.54 1 $0 (2023)
Dexcom, Inc. $140.42 1 $0 (2023)
Abbott Laboratories $121.98 1 $0 (2023)
Lilly USA, LLC $115.15 1 $0 (2023)
Xeris Pharmaceuticals, Inc. $93.64 1 $0 (2023)
Astellas Pharma US Inc $32.64 1 $0 (2023)
Merck Sharp & Dohme Corporation $19.68 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $110.40 2 Novo Nordisk Inc ($110.40)
2023 $652.37 6 Amgen Inc. ($148.54)
2022 $125.00 1 Boehringer Ingelheim Pharmaceuticals, Inc. ($125.00)
2021 $237.30 3 Boehringer Ingelheim Pharmaceuticals, Inc. ($116.00)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
01/12/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $31.15 General
01/05/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $79.25 General
12/06/2023 Xeris Pharmaceuticals, Inc. GVOKE HYPOPEN (Drug) Food and Beverage In-kind items and services $93.64 General
Category: Diabetes
12/05/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $148.54 General
Category: Cardiology
10/24/2023 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $32.64 General
Category: Biological
06/14/2023 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $121.98 General
Category: Diabetes Care
05/27/2023 Dexcom, Inc. DEXCOM G7 GSS (161) (Medical Supply) Food and Beverage In-kind items and services $140.42 General
Category: Endocrinology
04/06/2023 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage Cash or cash equivalent $115.15 General
Category: Diabetes
04/13/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $125.00 General
Category: DIABETES
11/04/2021 Novo Nordisk Inc RYBELSUS (Drug) Food and Beverage In-kind items and services $101.62 General
Category: Diabetes
10/20/2021 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $116.00 General
Category: DIABETES
02/18/2021 Merck Sharp & Dohme Corporation NEXPLANON (Drug) Food and Beverage In-kind items and services $19.68 General
Category: WOMENS HEALTH

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 227 250 $58,734 $15,859
2022 4 238 259 $47,422 $15,549
2021 3 232 247 $49,353 $16,973
2020 3 171 188 $33,442 $8,136
Total Patients
868
Total Services
944
Medicare Billing
$56,517
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 83 94 $27,555 $7,982 29.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 102 113 $24,758 $6,276 25.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 42 43 $6,421 $1,601 24.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 80 88 $21,250 $7,189 33.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 109 120 $21,480 $7,114 33.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 33 35 $4,340 $1,180 27.2%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Office 2022 16 16 $352.00 $66.07 18.8%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 109 120 $28,930 $10,671 36.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 81 85 $15,215 $4,832 31.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 42 42 $5,208 $1,471 28.2%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 127 144 $25,376 $6,759 26.6%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 24 24 $5,604 $799.68 14.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 20 20 $2,462 $577.19 23.4%

About Tanell Ogbeide, C.F.N.P

Tanell Ogbeide, C.F.N.P is a Obstetrics & Gynecology healthcare provider based in Lake Oswego, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2010. The National Provider Identifier (NPI) number assigned to this provider is 1609108687.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tanell Ogbeide, C.F.N.P has received a total of $1,125 in payments from pharmaceutical and medical device companies, with $110.40 received in 2024. These payments were reported across 12 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,125).

As a Medicare-enrolled provider, Ogbeide has provided services to 868 Medicare beneficiaries, totaling 944 services with total Medicare billing of $56,517. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Obstetrics & Gynecology
  • Other Specialties Nurse Practitioner, Nurse Practitioner
  • Location Lake Oswego, OR
  • Active Since 02/02/2010
  • Last Updated 11/02/2021
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • NPI Number 1609108687

Products in Payments

  • JARDIANCE (Drug) $241.00
  • Repatha (Biological) $148.54
  • DEXCOM G7 GSS (161) (Medical Supply) $140.42
  • FREESTYLE LIBRE 3 (Device) $121.98
  • MOUNJARO (Drug) $115.15
  • RYBELSUS (Drug) $101.62
  • GVOKE HYPOPEN (Drug) $93.64
  • Veozah (Drug) $32.64
  • NEXPLANON (Drug) $19.68

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.